Back to results
US 4,361,562 AGranted
3-Aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
AssigneeSandoz Ltd.
InventorRichard Berthold
Life of this patent
Estimating the term…
Abstract
The compounds of formula I ##STR1## where R.sub.1, R.sub.2 and R have various significances, and physiologically acceptable hydrolyzable derivatives thereof having the hydroxy group in the 2 position of the 3-aminopropoxy side chain in esterified form, are useful as cardiotonic, anti-arrhythmic, .alpha.- and .beta.-adrenoceptor blocking agents.
Claims29
A compound of formula I, ##STR58## wherein R.sub.1 is hydrogen or methyl,
- R.sub.2 is cyano and
- R is:
- (a) a group --B--CO--R.sub.h, wherein
- B is a group (i), (ii) or (iii), groups (i), (ii) and (iii) having the following significances:
- (i) ##STR59## wherein R.sub.i is hydrogen, alkyl of 1 to 4 carbon atoms, phenyl or phenyl monosubstituted or independently disubstituted by alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen of atomic number of from 9 to 35;
- (ii) ##STR60## wherein R.sub.j is hydrogen or alkyl of 1 to 4 carbon atoms;
- (iii) ##STR61## wherein n is 2, 3 or 4,
- R.sub.k is hydrogen or alkyl of 1 to 4 carbon atoms and
- R.sub.l has the significance indicated above for R.sub.i, and
- R.sub.h is phenylalkyl of 7 to 11 carbon atoms or diphenylalkyl of 13 to 17 carbon atoms, any of the phenyl rings of these two groups optionally being mono- or independently disubstituted by alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen of atomic number of from 9 to 35;
- (b) a group ##STR62## wherein R.sub.m is --COR.sub.n or --R.sub.p, wherein
- R.sub.n has the significance indicated above for R.sub.h and
- R.sub.p is phenyl monosubstituted by alkoxy of 1 to 4 carbon atoms or halogen of atomic number of from 9 to 35, phenyl independently disubstituted by alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen of atomic number of from 9 to 35, phenylalkyl of 7 to 11 carbon atoms or diphenylalkyl of 13 to 17 carbon atoms, any of the phenyl rings of these last two groups optionally being mono- or independently disubstituted by alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen of atomic number of from 9 to 35,
- and physiologically acceptable hydrolyzable derivatives thereof having the hydroxy group in the 2 position of the 3-aminopropoxy side chain in esterified form, or a pharmaceutically acceptable salt thereof.
11 more elements
Dependencies are inferred from the claim text.